149 related articles for article (PubMed ID: 11734666)
1. Comparative prevalence of antiphospholipid antibodies and thrombophilic genotypes in consecutive patients with venous thrombosis.
Cappucci G; Margaglione M; Ames PR
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):659-65. PubMed ID: 11734666
[TBL] [Abstract][Full Text] [Related]
2. Impact of plasma homocysteine and prothrombin G20210 A on primary antiphospholipid syndrome.
Ames PR; Margaglione M; Tommasino C; Bossone A; Iannaccone L; Brancaccio V
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):699-704. PubMed ID: 11734671
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies--prevalence and significance.
Ames PR; Tommasino C; D'Andrea G; Iannaccone L; Brancaccio V; Margaglione M
Thromb Haemost; 1998 Jan; 79(1):46-9. PubMed ID: 9459321
[TBL] [Abstract][Full Text] [Related]
4. The combination of thrombophilic genotypes is associated with definite antiphospholipid syndrome.
Forastiero R; Martinuzzo M; Adamczuk Y; Varela ML; Pombo G; Carreras LO
Haematologica; 2001 Jul; 86(7):735-41. PubMed ID: 11454529
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
6. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
[TBL] [Abstract][Full Text] [Related]
8. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5).
Gris JC; Quéré I; Monpeyroux F; Mercier E; Ripart-Neveu S; Tailland ML; Hoffet M; Berlan J; Daurès JP; Marès P
Thromb Haemost; 1999 Jun; 81(6):891-9. PubMed ID: 10404763
[TBL] [Abstract][Full Text] [Related]
9. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism.
Varela ML; Adamczuk YP; Forastiero RR; Martinuzzo ME; Cerrato GS; Pombo G; Carreras LO
Thromb Res; 2001 Dec; 104(5):317-24. PubMed ID: 11738073
[TBL] [Abstract][Full Text] [Related]
10. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.
Brouwer JL; Bijl M; Veeger NJ; Kluin-Nelemans HC; van der Meer J
Blood; 2004 Jul; 104(1):143-8. PubMed ID: 15026314
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
[TBL] [Abstract][Full Text] [Related]
12. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
[TBL] [Abstract][Full Text] [Related]
13. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
[TBL] [Abstract][Full Text] [Related]
14. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
Heller C; Schobess R; Kurnik K; Junker R; Günther G; Kreuz W; Nowak-Göttl U
Br J Haematol; 2000 Nov; 111(2):534-9. PubMed ID: 11122096
[TBL] [Abstract][Full Text] [Related]
15. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
16. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
19. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.
Mandala E; Lafaras C; Tsioni C; Speletas M; Papageorgiou A; Kleta D; Dardavessis T; Ilonidis G
Hippokratia; 2012 Jul; 16(3):250-5. PubMed ID: 23935293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
